US5171680A
(en)
|
1988-06-14 |
1992-12-15 |
Chiron Corporation |
Superoxide dismutase analogs having novel binding properties
|
ATE125566T1
(en)
|
1988-06-14 |
1995-08-15 |
Chiron Corp |
SUPEROXIDE DISMUTASE ANALOGS WITH NEW BINDING PROPERTIES.
|
FR2640638B1
(en)
|
1988-12-20 |
1991-02-15 |
Commissariat Energie Atomique |
BIOREACTOR AND DEVICE FOR THE CULTURE OF ANIMAL CELLS
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
US5693531A
(en)
|
1993-11-24 |
1997-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vector systems for the generation of adeno-associated virus particles
|
DE69535703T2
(en)
|
1994-04-13 |
2009-02-19 |
The Rockefeller University |
AAV-mediated delivery of DNA to cells of the nervous system
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
US20020159979A1
(en)
|
1994-06-06 |
2002-10-31 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
EP0796339A1
(en)
|
1994-12-06 |
1997-09-24 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant aav vectors
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US5756283A
(en)
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US5688676A
(en)
|
1995-06-07 |
1997-11-18 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
US6676935B2
(en)
|
1995-06-27 |
2004-01-13 |
Cell Genesys, Inc. |
Tissue specific adenoviral vectors
|
US6197293B1
(en)
|
1997-03-03 |
2001-03-06 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
|
US6143548A
(en)
|
1995-08-30 |
2000-11-07 |
Genzyme Corporation |
Chromatographic purification of adeno-associated virus (AAV)
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
US5846528A
(en)
|
1996-01-18 |
1998-12-08 |
Avigen, Inc. |
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
US5858351A
(en)
|
1996-01-18 |
1999-01-12 |
Avigen, Inc. |
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
JP4468488B2
(en)
|
1996-05-29 |
2010-05-26 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
Detection of nucleic acid sequence differences using combined ligase detection and polymerase chain reaction
|
US7026468B2
(en)
|
1996-07-19 |
2006-04-11 |
Valentis, Inc. |
Process and equipment for plasmid purification
|
AU4255397A
(en)
|
1996-09-06 |
1998-03-26 |
Trustees Of The University Of Pennsylvania, The |
Chimpanzee adenovirus vectors
|
US5866552A
(en)
|
1996-09-06 |
1999-02-02 |
The Trustees Of The University Of Pennsylvania |
Method for expressing a gene in the absence of an immune response
|
EP0931158A1
(en)
|
1996-09-06 |
1999-07-28 |
The Trustees Of The University Of Pennsylvania |
An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
|
US20020037867A1
(en)
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
EP0950111A1
(en)
|
1996-09-06 |
1999-10-20 |
The Trustees Of The University Of Pennsylvania |
Methods using cre-lox for production of recombinant adeno-associated viruses
|
EP0932418B1
(en)
|
1996-09-06 |
2007-12-05 |
The Trustees Of The University Of Pennsylvania |
Method for recombinant adeno-associated virus-directed gene therapy
|
WO1998011244A2
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
ATE348155T1
(en)
|
1996-11-20 |
2007-01-15 |
Introgen Therapeutics Inc |
AN IMPROVED METHOD FOR PRODUCTION AND PURIFICATION OF ADENOVIRAL VECTORS
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
EP0950091A2
(en)
|
1996-12-18 |
1999-10-20 |
Targeted Genetics Corporation |
Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
US6989264B2
(en)
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
WO1999015677A1
(en)
|
1997-09-19 |
1999-04-01 |
The Trustees Of The University Of Pennsylvania |
Method for gene transfer using bcl2 and compositions useful therein
|
AU9319198A
(en)
|
1997-09-19 |
1999-04-05 |
Trustees Of The University Of Pennsylvania, The |
Methods and vector constructs useful for production of recombinant aav
|
EP1015619A1
(en)
|
1997-09-19 |
2000-07-05 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
US6642051B1
(en)
|
1997-10-21 |
2003-11-04 |
Targeted Genetics Corporation |
Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors
|
IT1297074B1
(en)
|
1997-11-21 |
1999-08-03 |
Angeletti P Ist Richerche Bio |
HORMONE-DEPENDENT FORMS OF THE REP PROTEIN OF THE ADENUS ASSOCIATED VIRUS (AAV-2), DNA SEQUENCES CODING FOR THEM, VECTORS THAT
|
CA2316414A1
(en)
|
1997-12-23 |
1999-07-01 |
Introgene B.V. |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
AU2882899A
(en)
|
1998-02-26 |
1999-09-15 |
Trustees Of The University Of Pennsylvania, The |
Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
US6521426B1
(en)
|
1998-04-08 |
2003-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus
|
FR2778413B1
(en)
|
1998-05-07 |
2000-08-04 |
Immunotech Sa |
NOVEL REAGENTS AND METHOD FOR LYSIS OF ERYTHROCYTES
|
EP1078096A1
(en)
|
1998-05-11 |
2001-02-28 |
Ariad Gene Therapeutics, Inc. |
Multiviral compositions and uses thereof
|
EP1849872A1
(en)
|
1998-05-20 |
2007-10-31 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
WO1999061643A1
(en)
|
1998-05-27 |
1999-12-02 |
University Of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient
|
CA2329143A1
(en)
|
1998-05-27 |
1999-12-02 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated expression of factor viii activity
|
DE69939169D1
(en)
|
1998-05-28 |
2008-09-04 |
Us Gov Health & Human Serv |
AAV5 VECTORS AND THEIR USE
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
GB2338236B
(en)
|
1998-06-13 |
2003-04-09 |
Aea Technology Plc |
Microbiological cell processing
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
US6416992B1
(en)
|
1998-10-13 |
2002-07-09 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
MXPA01004169A
(en)
|
1998-10-27 |
2002-06-04 |
Crucell Holland Bv |
Improved aav vector production.
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
US6225113B1
(en)
|
1998-12-04 |
2001-05-01 |
Genvec, Inc. |
Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
DE19905501B4
(en)
|
1999-02-10 |
2005-05-19 |
MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie |
A method of producing a recombinant adeno-associated virus, suitable compositions therefor, and use for the manufacture of a medicament
|
US6509150B1
(en)
|
1999-03-05 |
2003-01-21 |
Universite De Nantes |
Compositions and methods for recombinant Adeno-Associated Virus production
|
JP4693244B2
(en)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Compositions and methods for helperless production of recombinant adeno-associated virus
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
JP2002542805A
(en)
|
1999-04-30 |
2002-12-17 |
ユニバーシティ オブ フロリダ |
Adeno-associated virus delivery ribozyme compositions and methods of use
|
CA2375098A1
(en)
|
1999-06-02 |
2000-12-14 |
Trustees Of The University Of Pennsylvania |
Compositions and methods useful for production of recombinant viruses which require helper viruses
|
JP4969002B2
(en)
|
1999-06-08 |
2012-07-04 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
Compounds and methods for increasing rAAV transduction
|
CA2382483A1
(en)
|
1999-08-20 |
2001-03-01 |
Johns Hopkins University School Of Medicine |
Methods and compositions for the construction and use of fusion libraries
|
JP2003523320A
(en)
|
1999-09-29 |
2003-08-05 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Methods for rapid PEG modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor
|
US6365394B1
(en)
|
1999-09-29 |
2002-04-02 |
The Trustees Of The University Of Pennsylvania |
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
|
US7241447B1
(en)
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
EP1224313A1
(en)
|
1999-10-07 |
2002-07-24 |
University of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
WO2001032711A2
(en)
|
1999-10-21 |
2001-05-10 |
Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
|
WO2001036623A2
(en)
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
AU1775901A
(en)
|
1999-11-17 |
2001-05-30 |
Avigen, Inc. |
Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
|
CA2392299A1
(en)
|
1999-12-10 |
2001-06-14 |
Victor Rivera |
Methods for expression of genes in primates
|
JP2003526377A
(en)
|
2000-03-14 |
2003-09-09 |
ニユーロロジクス・インコーポレーテツド |
Production of chimeric capsid vector
|
US7638120B2
(en)
|
2000-03-14 |
2009-12-29 |
Thomas Jefferson University |
High transgene expression of a pseudotyped adeno-associated virus type
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
US6468524B1
(en)
|
2000-03-22 |
2002-10-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
AAV4 vector and uses thereof
|
US7048920B2
(en)
|
2000-03-24 |
2006-05-23 |
Cell Genesys, Inc. |
Recombinant oncolytic adenovirus for human melanoma
|
EP2028278B1
(en)
|
2000-03-30 |
2014-03-19 |
Whitehead Institute For Biomedical Research |
RNA sequence-specific mediators of RNA interference
|
GB0009887D0
(en)
|
2000-04-20 |
2000-06-07 |
Btg Int Ltd |
Cytotoxic agents
|
US20030013189A1
(en)
|
2000-04-28 |
2003-01-16 |
Wilson James M. |
Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
AU2001255575B2
(en)
|
2000-04-28 |
2006-08-31 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
DE60117550T2
(en)
|
2000-06-01 |
2006-12-07 |
University Of North Carolina At Chapel Hill |
DOUBLE-SIDED PARVOVIRUS VECTORS
|
US20020106381A1
(en)
|
2000-06-13 |
2002-08-08 |
High Katherine A. |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
EP1302542B1
(en)
|
2000-07-18 |
2007-06-13 |
Takeda Pharmaceutical Company Limited |
Novel physiologically active peptide and use thereof
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
US20020111324A1
(en)
|
2000-08-17 |
2002-08-15 |
Keiya Ozawa |
Adeno-associated virus-mediated delivery of angiogenic factors
|
DE10044384A1
(en)
|
2000-09-08 |
2002-04-18 |
Medigene Ag |
Host cells for packaging recombinant adeno-associated virus (rAAV), process for their preparation and their use
|
FR2813891B1
(en)
|
2000-09-14 |
2005-01-14 |
Immunotech Sa |
MULTIFUNCTIONAL REAGENT FOR ERYTHROCYTES INVOLVING CARBAMATES AND APPLICATIONS
|
JP3758164B2
(en)
|
2000-10-24 |
2006-03-22 |
三菱ウェルファーマ株式会社 |
A therapeutic agent for amyotrophic lateral sclerosis (ALS)
|
JP2002153278A
(en)
|
2000-11-22 |
2002-05-28 |
Hisamitsu Pharmaceut Co Inc |
Cell for producing virus vector, method for producing the virus vector and method for producing virus vector using the cell
|
WO2002070719A2
(en)
|
2001-01-19 |
2002-09-12 |
Trustees Of The University Of Pennsylvania |
Regulatable gene expression system
|
US20030147853A1
(en)
|
2001-03-14 |
2003-08-07 |
Mcclelland Alan |
Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions
|
EP1404698A4
(en)
|
2001-06-21 |
2004-12-22 |
Isis Pharmaceuticals Inc |
Antisense modulation of superoxide dismutase 1, soluble expression
|
US20040136963A1
(en)
|
2001-06-22 |
2004-07-15 |
The Trustees Of The University Of Pennsylvania |
Simian adenovirus vectors and methods of use
|
ATE530672T1
(en)
|
2001-06-22 |
2011-11-15 |
Univ Pennsylvania |
RECOMBINANT ADENOVIRUSES WITH MONKEY ADENOVIRUS PROTEINS AND USE THEREOF.
|
EP1900815B1
(en)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
EP2345720A3
(en)
|
2001-07-12 |
2012-01-25 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
AU2007201330C1
(en)
|
2001-07-12 |
2011-06-09 |
University Of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
US8241622B2
(en)
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
EP1279740A1
(en)
|
2001-07-26 |
2003-01-29 |
Vrije Universiteit Brussel |
Recombinant vector derived from adeno-associated virus for gene therapy
|
AU2002349877B2
(en)
|
2001-08-08 |
2007-10-11 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
US20030092161A1
(en)
|
2001-09-19 |
2003-05-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for production of recombinant viruses, and uses therefor
|
EP2385123B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
EP1572893B1
(en)
|
2001-11-09 |
2009-01-07 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Production of adeno-associated virus in insect cells
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
DE60209193T2
(en)
|
2001-11-13 |
2006-09-28 |
Trustees Of The University Of Pennsylvania |
Method for identifying adeno-associated virus (AAV) sequences and kit for carrying out the method
|
EP1944043A1
(en)
|
2001-11-21 |
2008-07-16 |
The Trustees of the University of Pennsylvania |
Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
|
HU230364B1
(en)
|
2001-11-21 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Simian adeniovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
|
EP1453537A1
(en)
|
2001-12-12 |
2004-09-08 |
FH Faulding & Co. Limited |
Composition for viral preservation
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
EP2573170B1
(en)
|
2001-12-17 |
2017-12-20 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor
|
CA2469658A1
(en)
|
2001-12-19 |
2003-07-03 |
Lijun Wang |
Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
|
AU2003202026A1
(en)
|
2002-01-16 |
2003-09-02 |
Dynal Biotech Asa |
Method for isolating nucleic acids and protein from a single sample
|
US20030180756A1
(en)
|
2002-03-21 |
2003-09-25 |
Yang Shi |
Compositions and methods for suppressing eukaryotic gene expression
|
GB0208390D0
(en)
|
2002-04-11 |
2002-05-22 |
Univ London |
Adeno-associated virus producer system
|
US20030198620A1
(en)
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
WO2003093460A1
(en)
|
2002-04-29 |
2003-11-13 |
The Trustees Of The University Of Pennsylvania |
Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
|
DE60327069D1
(en)
|
2002-04-30 |
2009-05-20 |
Oncolytics Biotech Inc |
IMPROVED CLEANING METHOD FOR VIRUSES
|
CA2483624A1
(en)
|
2002-05-01 |
2004-04-01 |
University Of Florida Research Foundation, Inc. |
Improved raav expression systems for genetic modification of specific capsid proteins
|
ES2465574T3
(en)
|
2002-05-03 |
2014-06-06 |
Duke University |
A method to regulate gene expression
|
EP1506287B1
(en)
|
2002-05-14 |
2007-04-25 |
Merck & Co., Inc. |
Methods of adenovirus purification
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
US20070015238A1
(en)
|
2002-06-05 |
2007-01-18 |
Snyder Richard O |
Production of pseudotyped recombinant AAV virions
|
US20040241854A1
(en)
|
2002-08-05 |
2004-12-02 |
Davidson Beverly L. |
siRNA-mediated gene silencing
|
US20050255086A1
(en)
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
US7897380B2
(en)
|
2002-08-29 |
2011-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular nucleic acid vectors, and methods for making and using the same
|
AU2003273336A1
(en)
|
2002-09-18 |
2004-04-08 |
Isis Pharmaceuticals, Inc. |
Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
|
US7892793B2
(en)
|
2002-11-04 |
2011-02-22 |
University Of Massachusetts |
Allele-specific RNA interference
|
US20060041022A1
(en)
|
2002-11-06 |
2006-02-23 |
Pasinetti Giulio M |
Treatment of amyotrophic lateral sclerosis with nimesulide
|
EP1418185A1
(en)
|
2002-11-11 |
2004-05-12 |
Aventis Pharma Deutschland GmbH |
Use of EDG2 receptor in an animal model of heart failure
|
US7169612B2
(en)
|
2002-11-11 |
2007-01-30 |
Sanofi-Aventis Deutschland Gmbh |
Use of EDG2 receptor in an animal model of heart failure
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
ES2440284T3
(en)
|
2002-11-14 |
2014-01-28 |
Thermo Fisher Scientific Biosciences Inc. |
SiRNA directed to tp53
|
US7618948B2
(en)
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
CA2516425A1
(en)
|
2003-02-21 |
2005-02-24 |
The Penn State Research Foundation |
Rna interference compositions and methods
|
WO2004075861A2
(en)
|
2003-02-26 |
2004-09-10 |
Children's Hospital, Inc. |
Recombinant adeno-associated virus production
|
WO2004083441A2
(en)
|
2003-03-19 |
2004-09-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Random peptide library displayed on aav vectors
|
CN1829736A
(en)
*
|
2003-04-10 |
2006-09-06 |
希龙公司 |
The severe acute respiratory syndrome coronavirus
|
WO2004108922A2
(en)
|
2003-04-25 |
2004-12-16 |
The Trustees Of The University Of Pennsylvania |
Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
|
US8927269B2
(en)
|
2003-05-19 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Avian adenoassociated virus and uses thereof
|
EP2781596A1
(en)
|
2003-05-21 |
2014-09-24 |
Genzyme Corporation |
Methods for producing prepartions of recombinant AAVvirions substantially free of empty capsids
|
ES2712695T3
(en)
|
2003-06-02 |
2019-05-14 |
Univ Massachusetts |
Methods and compositions to control the efficiency of RNA silencing
|
US8309704B2
(en)
|
2003-06-02 |
2012-11-13 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNAi
|
US7750144B2
(en)
|
2003-06-02 |
2010-07-06 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
JP4888876B2
(en)
|
2003-06-13 |
2012-02-29 |
田平 武 |
Recombinant adeno-associated virus vector for the treatment of Alzheimer's disease
|
PL2657247T3
(en)
|
2003-06-19 |
2017-09-29 |
Genzyme Corporation |
AAV virions with decreased immunoreactivity and uses therefor
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
EP1636370B1
(en)
|
2003-06-20 |
2014-04-16 |
The Trustees of The University of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
WO2005007875A2
(en)
|
2003-07-18 |
2005-01-27 |
University Of Massachusetts |
Enhanced promoters for synthesis of small hairpin rna
|
WO2005012537A2
(en)
|
2003-07-25 |
2005-02-10 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
CA2533701A1
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
EP1668369B1
(en)
|
2003-08-20 |
2016-01-06 |
ProMIS Neurosciences Inc. |
Epitope protection assay and method for detecting protein conformations
|
US7947658B2
(en)
|
2003-09-12 |
2011-05-24 |
University Of Massachusetts |
RNA interference for the treatment of gain-of-function disorders
|
US20050064489A1
(en)
|
2003-09-24 |
2005-03-24 |
Zhang Fang Liang |
Engineered U6 and H1 promoters
|
PT2292780T
(en)
|
2003-09-30 |
2017-11-28 |
Univ Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses thereof
|
US7962316B2
(en)
|
2003-10-27 |
2011-06-14 |
Merck Sharp & Dohme Corp. |
Method of designing siRNAs for gene silencing
|
WO2005062937A2
(en)
|
2003-12-22 |
2005-07-14 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
|
DE602005027820D1
(en)
|
2004-03-05 |
2011-06-16 |
Benitec Inc |
MULTIPLE PROMOTER EXPRESSION CASSETTES FOR THE SIMULTANEOUS INTRODUCTION OF RNAI AGENTS
|
WO2005096781A2
(en)
|
2004-04-06 |
2005-10-20 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using rna interference
|
CA2563538C
(en)
|
2004-04-28 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations
|
EP1751275B1
(en)
|
2004-06-01 |
2017-08-16 |
Avigen, Inc. |
Compositions and methods to prevent aav vector aggregation
|
EP1807009B1
(en)
|
2004-10-05 |
2014-11-26 |
Genzyme Corporation |
Stepped cannula
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
CA2587854C
(en)
|
2004-11-18 |
2014-01-21 |
The Board Of Trustees Of The University Of Illinois |
Multicistronic sirna constructs to inhibit tumors
|
CN1286981C
(en)
|
2004-11-30 |
2006-11-29 |
华中科技大学同济医学院附属同济医院 |
Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
US20060229268A1
(en)
|
2004-12-16 |
2006-10-12 |
Alsgen, Llc |
Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)
|
JP4292416B2
(en)
|
2005-01-12 |
2009-07-08 |
住友電気工業株式会社 |
Superconducting cable terminal structure
|
CA2596711C
(en)
|
2005-02-03 |
2015-12-15 |
Benitec, Inc. |
Rnai expression constructs
|
US8614101B2
(en)
|
2008-05-20 |
2013-12-24 |
Rapid Pathogen Screening, Inc. |
In situ lysis of cells in lateral flow immunoassays
|
US7625570B1
(en)
|
2005-03-10 |
2009-12-01 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus
|
WO2006102072A2
(en)
|
2005-03-23 |
2006-09-28 |
The Trustees Of The University Of Pennsylvania |
Use of a pa131 polypeptide in treatment of atherosclerosis
|
DE23193601T1
(en)
|
2005-04-07 |
2024-02-15 |
The Trustees Of The University Of Pennsylvania |
METHOD FOR INCREASE THE FUNCTION OF AN AAV VECTOR
|
WO2006119432A2
(en)
|
2005-04-29 |
2006-11-09 |
The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services |
Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
|
PT3058959T
(en)
|
2005-05-02 |
2019-05-24 |
Genzyme Corp |
Gene therapy for neurometabolic disorders
|
EP1937066A4
(en)
|
2005-08-18 |
2008-12-24 |
Alnylam Pharmaceuticals Inc |
Methods and compositions for treating neurological disease
|
JP5238503B2
(en)
|
2005-08-23 |
2013-07-17 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
Anti-reflux cannula and system for chronic delivery of therapeutic agents using enhanced convection delivery
|
EP1857552A1
(en)
|
2006-05-20 |
2007-11-21 |
Cargill Incorporated |
Thermostable xylose isomerase enzyme
|
WO2007046703A2
(en)
|
2005-10-20 |
2007-04-26 |
Amsterdam Molecular Therapeutics B.V. |
Improved aav vectors produced in insect cells
|
US7887803B2
(en)
|
2005-12-02 |
2011-02-15 |
Amorfix Life Sciences |
Methods and compositions to treat misfolded-SOD1 mediated diseases
|
US7794692B2
(en)
|
2005-12-02 |
2010-09-14 |
Amorfix Life Sciences Ltd. |
Methods and compositions for detecting amyotrophic lateral sclerosis
|
WO2007089607A2
(en)
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
WO2007089632A2
(en)
|
2006-01-27 |
2007-08-09 |
The University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
DK2514823T3
(en)
|
2006-03-03 |
2018-07-23 |
Promis Neurosciences Inc |
Methods and compositions for treating and detecting failed SOD1-mediated diseases
|
EP1993611A4
(en)
|
2006-03-16 |
2013-05-22 |
Alnylam Pharmaceuticals Inc |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
CA3024953A1
(en)
|
2006-04-03 |
2007-10-11 |
Roche Innovation Center Copenhagen A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
WO2008010864A2
(en)
|
2006-04-28 |
2008-01-24 |
The Trustees Of The University Of Pennsylvania |
Modified adenovirus hexon protein and uses thereof
|
CN101495624A
(en)
|
2006-04-28 |
2009-07-29 |
宾夕法尼亚州立大学托管会 |
Modified AAV vectors having reduced capsid immunogenicity and use thereof
|
ES2400235T3
(en)
|
2006-04-28 |
2013-04-08 |
The Trustees Of The University Of Pennsylvania |
AAV scalable production method
|
WO2007130519A2
(en)
|
2006-05-02 |
2007-11-15 |
Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Viral nucleic acid microarray and method of use
|
AU2007253909B2
(en)
|
2006-05-05 |
2012-08-09 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of GCCR
|
CA2651499C
(en)
|
2006-05-25 |
2015-06-30 |
Sangamo Biosciences, Inc. |
Methods and compositions for ccr-5 gene inactivation
|
CN101506369B
(en)
|
2006-06-21 |
2014-02-12 |
尤尼克尔生物制药股份有限公司 |
Vectors with modified initiation codon for translation of AAV-REP78 useful for production of AAV in insect cells
|
SG173337A1
(en)
|
2006-07-21 |
2011-08-29 |
California Inst Of Techn |
Targeted gene delivery for dendritic cell vaccination
|
ES2385679T3
(en)
|
2006-08-24 |
2012-07-30 |
Virovek, Inc. |
Expression of gene insect cells with overlapping open reading frames, methods and compositions thereof
|
PT2066791E
(en)
|
2006-10-03 |
2012-12-05 |
Genzyme Corp |
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
|
US7794443B2
(en)
|
2006-10-24 |
2010-09-14 |
Medtronic, Inc. |
System and method for intraparenchymal drug infusion
|
EP2799547B1
(en)
|
2006-11-08 |
2016-12-21 |
Veritas Bio, LLC |
In Vivo Delivery of RNA to a Target Cell
|
WO2008067480A2
(en)
|
2006-11-29 |
2008-06-05 |
Nationwide Children's Hospital |
Myostatin inhibition for enhancing muscle and/or improving muscle function
|
US8227592B2
(en)
|
2006-11-29 |
2012-07-24 |
University Of Iowa Research Foundation |
Alternative export pathways for vector expressed RNA interference
|
WO2008086079A2
(en)
|
2007-01-03 |
2008-07-17 |
Medtronic, Inc. |
Compositions comprising rnai and a neurotrophic factor and uses thereof
|
US8173614B2
(en)
|
2007-01-03 |
2012-05-08 |
Medtronic, Inc. |
Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
|
NZ578816A
(en)
|
2007-02-02 |
2012-06-29 |
Biogen Idec Inc |
Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
US9611302B2
(en)
|
2007-04-09 |
2017-04-04 |
University Of Florida Research Foundation, Inc. |
High-transduction-efficiency RAAV vectors, compositions, and methods of use
|
ES2714007T3
(en)
|
2007-04-09 |
2019-05-24 |
Univ Florida |
Compositions of rAAV vectors that have tyrosine modified capsid proteins and methods for their use
|
WO2008128251A1
(en)
|
2007-04-17 |
2008-10-23 |
The Children's Hospital Of Philadelphia |
Humanized viral vectors and methods of use thereof
|
WO2008134646A2
(en)
|
2007-04-26 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna interference suppression of neurodegenerative diseases and methods of use thereof
|
US20100203083A1
(en)
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
EP2012122A1
(en)
|
2007-07-06 |
2009-01-07 |
Medigene AG |
Mutated parvovirus structural proteins as vaccines
|
WO2008150897A2
(en)
|
2007-05-31 |
2008-12-11 |
University Of Iowa Research Foundation |
Reduction of off-target rna interference toxicity
|
US8841437B2
(en)
|
2008-06-20 |
2014-09-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Precursor miRNA loop-modulated target regulation
|
BRPI0813003A2
(en)
|
2007-06-29 |
2014-10-14 |
Hoffmann La Roche |
DISTRICT ATTORNEY
|
CA2728571A1
(en)
|
2007-06-29 |
2009-01-08 |
Boston Biomedical, Inc. |
Bacteria-mediated gene modulation via microrna machinery
|
EP3121190A1
(en)
|
2007-07-14 |
2017-01-25 |
University of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
CN101868547B
(en)
|
2007-07-26 |
2016-03-16 |
尤尼克尔Ip股份有限公司 |
Comprise the baculovirus vector of the repeated encoding sequence with difference codon bias
|
EP2193140B1
(en)
|
2007-08-27 |
2016-11-02 |
1Globe Health Institute LLC |
Compositions of asymmetric interfering rna and uses thereof
|
WO2009030025A1
(en)
|
2007-09-04 |
2009-03-12 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Porcine adeno-associated viruses
|
ES2426091T3
(en)
|
2007-09-19 |
2013-10-21 |
Uniqure Ip B.V. |
Use of AAV replication machinery for improved protein production
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
BRPI0819783A2
(en)
|
2007-11-28 |
2015-06-23 |
Univ Pennsylvania |
Simian subfamily and adenovirus sadv-39, -25.2, -26, -30, -37 and -38 and uses thereof.
|
CA2707029A1
(en)
|
2007-11-28 |
2009-08-27 |
Soumitra Roy |
Simian subfamily c adenoviruses sadv-40, -31, and -34 and uses thereof
|
PL2220242T3
(en)
|
2007-11-28 |
2017-09-29 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily b adenoviruses sadv-28,27,-29,-32,-33, and -35 and uses thereof
|
US8480626B2
(en)
|
2007-11-30 |
2013-07-09 |
Medtronic, Inc. |
Infusion catheter assembly with reduced backflow
|
WO2009126350A2
(en)
|
2008-01-18 |
2009-10-15 |
Genentech, Inc. |
Methods and compositions for targeting polyubiquitin
|
ES2751999T3
(en)
|
2008-01-29 |
2020-04-02 |
Applied Genetic Tech Corporation |
Recombinant production of adeno-associated viruses using suspension BHK cells
|
US10131904B2
(en)
|
2008-02-11 |
2018-11-20 |
Rxi Pharmaceuticals Corporation |
Modified RNAi polynucleotides and uses thereof
|
ES2929031T3
(en)
|
2008-02-19 |
2022-11-24 |
Uniqure Ip Bv |
Optimization of parvoviral rep and cap protein expression in insect cells
|
CN102016011B
(en)
|
2008-03-04 |
2013-12-11 |
宾夕法尼亚大学托管会 |
Simian adenoviruses SADV-36,-42.1, -42.2, and -44 and uses thereof
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
WO2009134681A2
(en)
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
WO2010011404A2
(en)
|
2008-05-20 |
2010-01-28 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
US8951979B2
(en)
|
2008-06-13 |
2015-02-10 |
Cornell University |
Pain treatment using ERK2 inhibitors
|
US20110171262A1
(en)
|
2008-06-17 |
2011-07-14 |
Andrew Christian Bakker |
Parvoviral capsid with incorporated gly-ala repeat region
|
US8945885B2
(en)
|
2008-07-03 |
2015-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Minicircle DNA vector preparations and methods of making and using the same
|
JP5328244B2
(en)
|
2008-07-07 |
2013-10-30 |
株式会社ニュージェン・ファーマ |
A therapeutic agent for amyotrophic lateral sclerosis
|
CA2731779A1
(en)
|
2008-07-24 |
2010-01-28 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
US8212019B2
(en)
|
2008-07-30 |
2012-07-03 |
University Of Massachusetts |
Nucleic acid silencing sequences
|
AU2009293658A1
(en)
|
2008-09-22 |
2010-03-25 |
James Cardia |
Reduced size self-delivering RNAi compounds
|
MX2011003229A
(en)
|
2008-09-29 |
2011-09-06 |
Proyecto Biomedicina Cima Sl |
Porphobilinogen deaminase gene therapy.
|
JP5851838B2
(en)
|
2008-10-22 |
2016-02-03 |
ジェネンテック, インコーポレイテッド |
Regulation of axonal degeneration
|
US8940290B2
(en)
|
2008-10-31 |
2015-01-27 |
The Trustees Of The University Of Pennsylvania |
Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
BRPI1013364A2
(en)
|
2009-03-04 |
2016-03-29 |
Deutsches Krebsforsch |
assembly activating protein (aap) and its use for the manufacture of parvovirus particles consisting essentially of vp3.
|
MX2011010097A
(en)
|
2009-03-27 |
2011-10-19 |
Proyecto Biomedicina Cima Sl |
Methods and compositions for the treatment of cirrhosis and liver fibrosis.
|
ES2724122T3
(en)
|
2009-04-30 |
2019-09-06 |
Univ Pennsylvania |
Compositions for directing conductive airway cells comprising adeno-associated virus constructs
|
EP2772542B1
(en)
|
2009-05-28 |
2016-12-28 |
Deutsches Krebsforschungszentrum |
Modified AAV capsid polypeptides
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
CN102575232B
(en)
|
2009-05-29 |
2015-07-22 |
宾夕法尼亚大学托管会 |
Simian adenovirus 41 and uses thereof
|
SG176283A1
(en)
|
2009-06-16 |
2012-01-30 |
Genzyme Corp |
Improved methods for purification of recombinant aav vectors
|
EP2451823A4
(en)
|
2009-07-06 |
2013-07-03 |
Alnylam Pharmaceuticals Inc |
Compositions and methods for enhancing production of a biological product
|
JP5828838B2
(en)
|
2009-07-15 |
2015-12-09 |
カリミューン, インコーポレーティッド |
Dual vector for human immunodeficiency virus inhibition
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
WO2011038187A1
(en)
|
2009-09-25 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Controlled adeno-associated virus (aav) diversification and libraries prepared therefrom
|
EP2498825B1
(en)
|
2009-11-09 |
2017-03-29 |
Genepod Therapeutics Ab |
Novel viral vector construct for neuron specific continuous dopa synthesis in vivo
|
AU2010322723B9
(en)
|
2009-11-19 |
2015-03-05 |
Momotaro-Gene Inc. |
System for increasing gene expression and vector comprising the system
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
ES2683695T3
(en)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Inverse restrictive terminal repeats for viral vectors
|
US9169492B2
(en)
|
2010-02-05 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
US9163261B2
(en)
|
2010-02-22 |
2015-10-20 |
Koteswara Rao KOLLIPARA |
Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
WO2011117258A2
(en)
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
SG10201502270TA
(en)
|
2010-03-29 |
2015-05-28 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
EP3444346B1
(en)
|
2010-04-23 |
2022-07-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
CA3066596A1
(en)
|
2010-04-23 |
2011-10-27 |
University Of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
CA3050894C
(en)
|
2010-04-23 |
2022-10-18 |
University Of Massachusetts |
Multicistronic expression constructs
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
US9839696B2
(en)
|
2010-04-30 |
2017-12-12 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
US9856210B2
(en)
|
2010-09-02 |
2018-01-02 |
Kyoto University |
Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
|
US8808684B2
(en)
|
2010-09-10 |
2014-08-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
|
WO2012046727A1
(en)
|
2010-10-05 |
2012-04-12 |
タカラバイオ株式会社 |
Method for producing virus vector
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
CN107828820B
(en)
|
2010-10-27 |
2022-06-07 |
学校法人自治医科大学 |
Adeno-associated virus particles for gene transfer into nervous system cells
|
US20130236433A1
(en)
|
2010-11-11 |
2013-09-12 |
Keith A. Webster |
Methods, compositions, cells, and kits for treating ischemic injury
|
AU2011332025B2
(en)
|
2010-11-23 |
2015-06-25 |
The Trustees Of The University Of Pennsylvania |
Subfamily E simian adenoviruses A1321, A1325, A1295, A1309 and A1322 and uses thereof
|
WO2012109667A1
(en)
|
2011-02-12 |
2012-08-16 |
University Of Iowa Research Foundation |
Therapeutic compounds
|
SG10202007803QA
(en)
|
2011-02-17 |
2020-09-29 |
Univ Pennsylvania |
Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
|
GB201103062D0
(en)
|
2011-02-22 |
2011-04-06 |
Isis Innovation |
Method
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
JP6007463B2
(en)
|
2011-04-18 |
2016-10-12 |
国立研究開発法人国立精神・神経医療研究センター |
Drug delivery particle and method for producing the same
|
EP3699286A1
(en)
|
2011-04-20 |
2020-08-26 |
The Trustees of the University of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
SG194583A1
(en)
|
2011-04-22 |
2013-12-30 |
Univ California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
WO2012149646A1
(en)
|
2011-05-05 |
2012-11-08 |
Sunnybrook Research Institute |
Mirna inhibitors and their uses
|
US9249425B2
(en)
|
2011-05-16 |
2016-02-02 |
The Trustees Of The University Of Pennslyvania |
Proviral plasmids and production of recombinant adeno-associated virus
|
WO2012159006A2
(en)
|
2011-05-18 |
2012-11-22 |
University Of Florida Research Foundation, Inc. |
Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof
|
CA2831969A1
(en)
|
2011-06-06 |
2012-12-30 |
Biocartis S.A. |
Selective lysis of cells by ionic surfactants
|
US20130019580A1
(en)
|
2011-07-20 |
2013-01-24 |
Anderson Noel W |
Bidirectional harvesting system
|
IN2014CN00688A
(en)
|
2011-07-27 |
2015-04-03 |
Genethon |
|
US8852911B2
(en)
|
2011-08-04 |
2014-10-07 |
The Regents Of The University Of California |
Method of producing dicer
|
US9840694B2
(en)
|
2011-09-08 |
2017-12-12 |
Uniqure Ip B.V. |
Removal of contaminating viruses from AAV preparations
|
US9056892B2
(en)
|
2011-09-09 |
2015-06-16 |
University Of Washington |
Retrograde transport peptide and use of same for delivery to central nervous system
|
CN104520421B
(en)
|
2011-10-28 |
2017-05-24 |
北卡罗来纳-查佩尔山大学 |
Cell line for production of adeno-associated virus
|
US10640785B2
(en)
|
2011-11-22 |
2020-05-05 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
US9611305B2
(en)
|
2012-01-06 |
2017-04-04 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
JP2013143917A
(en)
|
2012-01-13 |
2013-07-25 |
Mie Univ |
Preventive or therapeutic agent for fibrosis
|
HUE036640T2
(en)
|
2012-02-14 |
2018-07-30 |
Univ California |
Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
|
MX367100B
(en)
|
2012-02-17 |
2019-08-05 |
The Children´S Hospital Of Philadelphia |
Aav vector compositions and methods for gene transfer to cells, organs and tissues.
|
SG11201406776TA
(en)
|
2012-04-18 |
2015-03-30 |
Philadelphia Children Hospital |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
US20140162319A2
(en)
|
2012-05-02 |
2014-06-12 |
Sangeetha Hareendran |
Nucleotide sequences, methods, kit and a recombinant cell thereof
|
US9163259B2
(en)
|
2012-05-04 |
2015-10-20 |
Novartis Ag |
Viral vectors for the treatment of retinal dystrophy
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
TWI775096B
(en)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
Treatment of amd using aav sflt-1
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
CN105473723A
(en)
|
2012-05-18 |
2016-04-06 |
宾夕法尼亚大学托管会 |
Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
|
US9539259B2
(en)
|
2012-05-23 |
2017-01-10 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
IN2015KN00074A
(en)
|
2012-07-06 |
2015-07-31 |
Univ Iowa Res Found |
|
CN104603272B
(en)
|
2012-07-06 |
2017-11-07 |
宝生物工程株式会社 |
The cell of adeno-associated virus vector can be produced
|
US9556433B2
(en)
|
2012-07-17 |
2017-01-31 |
Université De Genève |
Nucleic acids for down-regulation of gene expression
|
WO2014022582A1
(en)
|
2012-08-01 |
2014-02-06 |
Nationwide Children's Hospital, Inc. |
Intrathecal delivery of recombinant adeno-associated virus 9
|
JP2015529685A
(en)
|
2012-09-17 |
2015-10-08 |
ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルThe Research Institute Atnationwide Children’S Hospital |
Compositions and methods for the treatment of amyotrophic lateral sclerosis
|
CN104797593B
(en)
|
2012-09-28 |
2020-05-08 |
北卡罗来纳-查佩尔山大学 |
AAV vectors targeting oligodendrocytes
|
US20140243783A1
(en)
|
2012-10-06 |
2014-08-28 |
Raghu Raghavan |
Method of backflow reduction during material delivery through a needle into tissue
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
US9733237B2
(en)
|
2012-10-31 |
2017-08-15 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying candidates for the treatment of neurodegenerative diseases
|
EP2914728B1
(en)
|
2012-11-01 |
2020-07-08 |
Factor Bioscience Inc. |
Methods and products for expressing proteins in cells
|
US20140179770A1
(en)
|
2012-12-12 |
2014-06-26 |
Massachusetts Institute Of Technology |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
|
WO2014103957A1
(en)
|
2012-12-25 |
2014-07-03 |
タカラバイオ株式会社 |
Aav variant
|
RU2015133252A
(en)
|
2013-01-08 |
2017-02-10 |
Бенитек Байофарма Лимитед |
TREATMENT OF AGE-RELATED MACULAR DEGENERATION
|
ES2741502T3
(en)
|
2013-02-08 |
2020-02-11 |
Univ Pennsylvania |
AAV8 capsid modified for gene transfer for retinal therapies
|
JP2016514152A
(en)
|
2013-03-13 |
2016-05-19 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Adeno-associated virus vector and method of use thereof
|
WO2014144844A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA DERIVED SMALL RNAs (tsRNAs) INVOLVED IN CELL VIABILITY
|
EP3517612A1
(en)
|
2013-03-15 |
2019-07-31 |
The University of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
EP2970943A4
(en)
|
2013-03-15 |
2017-04-19 |
The Children's Hospital of Philadelphia |
Vectors comprising stuffer/filler polynucleotide sequences and methods of use
|
US9828587B2
(en)
|
2013-04-08 |
2017-11-28 |
University Of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
US10494645B2
(en)
|
2013-04-18 |
2019-12-03 |
Fondazione Telethon |
Effective delivery of large genes by dual AAV vectors
|
CA2909807C
(en)
|
2013-04-20 |
2023-08-08 |
Research Institute At Nationwide Children's Hospital |
Recombinant adeno-associated virus delivery of exon 2-targeted u7snrna polynucleotide constructs
|
WO2015012924A2
(en)
|
2013-04-29 |
2015-01-29 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof
|
US9827295B2
(en)
|
2013-05-15 |
2017-11-28 |
Regents Of The University Of Minnesota |
Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase
|
US10006049B2
(en)
|
2013-05-16 |
2018-06-26 |
University Of Florida Research Foundation, Incorporated |
Hairpin mRNA elements and methods for the regulation of protein translation
|
CN105247044B
(en)
|
2013-05-31 |
2021-05-07 |
加利福尼亚大学董事会 |
Adeno-associated virus variants and methods of use thereof
|
WO2014201308A1
(en)
|
2013-06-12 |
2014-12-18 |
Washington University |
Endothelial-targeted adenoviral vectors, methods and uses therefor
|
US20160122727A1
(en)
|
2013-06-13 |
2016-05-05 |
Shire Human Genetic Therapies, Inc. |
Messenger rna based viral production
|
KR20220041963A
(en)
|
2013-07-22 |
2022-04-01 |
더 칠드런스 호스피탈 오브 필라델피아 |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
EP3024497B1
(en)
|
2013-07-26 |
2021-01-13 |
University of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
ITTO20130669A1
(en)
|
2013-08-05 |
2015-02-06 |
Consiglio Nazionale Ricerche |
ADENO-ASSOCIATED MOMCULAR-SPECIFIC VECTOR AND ITS EMPLOYMENT IN THE TREATMENT OF MUSCLE PATHOLOGIES
|
KR20160106040A
(en)
|
2013-08-14 |
2016-09-09 |
퀴아젠 맨스필드, 인코퍼레이티드 |
Compositions and methods for multimodal analysis of cmet nucleic acids
|
PL3702466T3
(en)
|
2013-08-27 |
2023-04-24 |
Research Institute At Nationwide Children's Hospital |
Products and methods for treatment of amyotrophic lateral sclerosis
|
EP3039129B1
(en)
|
2013-08-30 |
2018-06-27 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
WO2015044292A1
(en)
|
2013-09-26 |
2015-04-02 |
Universitat Autonoma De Barcelona |
Gene therapy compositions for use in the prevention and/or treatment of non-alcoholic fatty liver disease
|
EP3049527A4
(en)
|
2013-09-26 |
2017-08-16 |
University of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
EP3744730A1
(en)
|
2013-10-11 |
2020-12-02 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
WO2015069647A1
(en)
|
2013-11-05 |
2015-05-14 |
The Research Institute At Nationwide Children's Hospital |
COMPOSITIONS AND METHODS FOR INHIBITING NF- kB AND SOD-1 TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
|
US20160272687A1
(en)
|
2013-11-08 |
2016-09-22 |
The Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus "x" oncogene
|
JP6649265B2
(en)
|
2013-11-26 |
2020-02-19 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
Adeno-associated virus vector for treatment of glycogen disease
|
WO2015080223A1
(en)
|
2013-11-29 |
2015-06-04 |
タカラバイオ株式会社 |
Method for quantifying adeno-associated virus
|
WO2015084254A1
(en)
|
2013-12-03 |
2015-06-11 |
Agency For Science, Technology And Research |
Tailed Mirtron Effectors For RNAi-Mediated Gene Silencing
|
DK3080269T3
(en)
|
2013-12-09 |
2019-07-08 |
Baylor College Medicine |
HIPPO AND DYSTROPHIN COMPLEX SIGNALING BY CARDIOMYOCYTY RENEW
|
JP6712948B2
(en)
|
2013-12-12 |
2020-06-24 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
Compositions and methods of using the CRISPR-cas system in nucleotide repeat disorders
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
GB201401707D0
(en)
|
2014-01-31 |
2014-03-19 |
Sec Dep For Health The |
Adeno-associated viral vectors
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
WO2015124546A1
(en)
|
2014-02-19 |
2015-08-27 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic |
Aav vectors for the treatment of ischemic and non-ischemic heart disease
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
US20170007720A1
(en)
|
2014-02-21 |
2017-01-12 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
WO2015134643A1
(en)
|
2014-03-04 |
2015-09-11 |
University Of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
CA2942289A1
(en)
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
AU2015231294B2
(en)
|
2014-03-18 |
2020-10-29 |
University Of Massachusetts |
rAAV-based compositions and methods for treating amyotrophic lateral sclerosis
|
KR20220077933A
(en)
*
|
2014-04-01 |
2022-06-09 |
바이오젠 엠에이 인코포레이티드 |
Compositions for modulating sod-1 expression
|
EP2933335A1
(en)
|
2014-04-18 |
2015-10-21 |
Genethon |
A method of treating peripheral neuropathies and motor neuron diseases
|
JP6741590B2
(en)
|
2014-04-25 |
2020-08-19 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
LDLR variants for lowering cholesterol levels and their use in compositions
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
US9194250B1
(en)
|
2014-05-07 |
2015-11-24 |
General Electric Company |
Embedded wireless sensors for turbomachine component defect monitoring
|
CN106413760B
(en)
|
2014-05-08 |
2020-01-14 |
桑格摩生物科学股份有限公司 |
Methods and compositions for treating huntington's disease
|
US20170088819A1
(en)
|
2014-05-16 |
2017-03-30 |
Vrije Universiteit Brussel |
Genetic correction of myotonic dystrophy type 1
|
CN107075514A
(en)
|
2014-05-20 |
2017-08-18 |
衣阿华大学研究基金会 |
The therapeutic compounds of Huntington's disease
|
EP3160980B1
(en)
|
2014-05-28 |
2020-05-20 |
The Regents of the University of California |
HYBRID tRNA/pre-miRNA MOLECULES AND METHODS OF USE
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
WO2015192063A1
(en)
|
2014-06-13 |
2015-12-17 |
Yasuhiro Ikeda |
Methods and materials for increasing viral vector infectivity
|
WO2015196179A1
(en)
|
2014-06-20 |
2015-12-23 |
University Of Florida Research Foundation, Inc. |
Methods of packaging multiple adeno-associated virus vectors
|
WO2016004319A1
(en)
|
2014-07-02 |
2016-01-07 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for purifying recombinant adeno-associated virus
|
EP3168298B1
(en)
|
2014-07-10 |
2019-04-17 |
Takara Bio Inc. |
Production method for non-enveloped virus particles
|
ES2806087T3
(en)
|
2014-07-31 |
2021-02-16 |
Association Inst De Myologie |
Treatment of amyotrophic lateral sclerosis
|
US10392622B2
(en)
|
2014-08-01 |
2019-08-27 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for self-regulated inducible gene expression
|
WO2016040347A2
(en)
|
2014-09-08 |
2016-03-17 |
University Of Iowa Research Foundation |
Microrna inhibitor system and methods of use thereof
|
JP6842410B2
(en)
|
2014-10-03 |
2021-03-17 |
ユニバーシティ オブ マサチューセッツ |
AAV vector identified by a novel high efficiency library
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
US10842886B2
(en)
|
2014-10-10 |
2020-11-24 |
Research Institute At Nationwide Children's Hospital |
Guided injections for AAV gene transfer to muscle
|
RU2020140209A
(en)
|
2014-10-21 |
2021-01-25 |
Юниверсити Оф Массачусетс |
RECOMBINANT AAV OPTIONS AND THEIR APPLICATIONS
|
WO2016077607A1
(en)
|
2014-11-13 |
2016-05-19 |
The Regents Of The University Of California |
Adjustable stepped cannula
|
CA3193811A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
WO2016077689A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
WO2016081811A1
(en)
|
2014-11-21 |
2016-05-26 |
The University Of North Carolina At Chapel Hill |
Aav vectors targeted to the central nervous system
|
US10900053B2
(en)
|
2014-11-21 |
2021-01-26 |
University Of Florida Research Foundation, Incorporated |
Genome-modified recombinant adeno-associated virus vectors
|
ES2751919T5
(en)
|
2014-11-28 |
2023-10-04 |
Uniqure Ip Bv |
DNA impurities in a composition comprising a parvoviral virion
|
JP6938377B2
(en)
|
2015-01-14 |
2021-09-22 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
Methods and compositions for targeting gene transfer
|
CA2970730A1
(en)
|
2015-01-16 |
2016-07-21 |
Voyager Therapeutics, Inc. |
Central nervous system targeting polynucleotides
|
JP2018506530A
(en)
|
2015-01-30 |
2018-03-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Spinal subpuffy gene delivery system
|
WO2016126857A1
(en)
|
2015-02-03 |
2016-08-11 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
JP6928558B2
(en)
|
2015-02-10 |
2021-09-01 |
ジェンザイム・コーポレーション |
Enhanced delivery of viral particles to the striatum and cortex
|
WO2016137949A1
(en)
|
2015-02-23 |
2016-09-01 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
WO2016154055A1
(en)
|
2015-03-20 |
2016-09-29 |
Bluebird Bio, Inc. |
Vector formulations
|
CN107532177A
(en)
|
2015-03-24 |
2018-01-02 |
加利福尼亚大学董事会 |
Adeno-associated virus variant and its application method
|
US9809817B2
(en)
|
2015-04-03 |
2017-11-07 |
University Of Massachusetts |
Oligonucleotide compounds for targeting huntingtin mRNA
|
JP6892433B2
(en)
|
2015-04-03 |
2021-06-23 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
Well-stabilized asymmetric SIRNA
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
TWI707951B
(en)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
Production of oversized adeno-associated vectors
|
CN115074366A
(en)
|
2015-04-16 |
2022-09-20 |
埃默里大学 |
Recombinant promoter and vector for protein expression in liver and application thereof
|
CA3019315A1
(en)
|
2015-04-23 |
2016-10-27 |
University Of Massachusetts |
Modulation of aav vector transgene expression
|
CA3021949C
(en)
|
2015-04-24 |
2023-10-17 |
University Of Massachusetts |
Modified aav constructs and uses thereof
|
US20160346359A1
(en)
|
2015-05-01 |
2016-12-01 |
Spark Therapeutics, Inc. |
Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
|
CA2985223A1
(en)
|
2015-05-07 |
2016-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods of delivering an agent to the eye
|
JP6993234B2
(en)
|
2015-05-11 |
2022-01-13 |
アルキオーネ・ライフサイエンシズ・インコーポレイテッド |
Drug delivery system and method
|
EP3294894B8
(en)
|
2015-05-12 |
2019-09-25 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
US20170067028A1
(en)
|
2015-05-15 |
2017-03-09 |
Douglas J. Ballon |
Radiolabeling of adeno associated virus
|
US10729790B2
(en)
|
2015-05-26 |
2020-08-04 |
Salk Institute For Biological Studies |
Motor neuron-specific expression vectors
|
IL255912B2
(en)
|
2015-05-29 |
2023-10-01 |
Univ Pennsylvania |
Compositions and methods for degradation of misfolded proteins
|
WO2016196507A1
(en)
|
2015-05-29 |
2016-12-08 |
University Of Iowa Research Foundation |
Methods of delivery of transgenes for treating brain diseases
|
WO2017004514A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Florida Research Foundation, Inc. |
Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma
|
US20170009304A1
(en)
|
2015-07-07 |
2017-01-12 |
Splicingcodes.Com |
Method and kit for detecting fusion transcripts
|
US20170007669A1
(en)
|
2015-07-07 |
2017-01-12 |
Mayo Foundation For Medical Education And Research |
Peptide-mediated delivery of active agents across the blood-brain barrier
|
EP3320101B1
(en)
|
2015-07-07 |
2021-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
|
US20180216133A1
(en)
|
2015-07-17 |
2018-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
WO2017019876A1
(en)
|
2015-07-28 |
2017-02-02 |
University Of Massachusetts |
Transgenic expression of dnase i in vivo delivered by an adeno-associated virus vector
|
US10738087B2
(en)
|
2015-07-30 |
2020-08-11 |
Massachusetts Eye And Ear Infirmary |
Ancestral virus sequences and uses thereof
|
WO2017024111A1
(en)
|
2015-08-04 |
2017-02-09 |
The University Of Chicago |
Inhibitors of cacna1a/alpha1a subunit internal ribosomal entry site (ires) and methods of treating spinocerebellar ataxia type 6
|
US10047377B2
(en)
|
2015-09-22 |
2018-08-14 |
Loyola University Of Chicago |
Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
|
IL299901A
(en)
|
2015-09-28 |
2023-03-01 |
Univ Florida |
Methods and compositions for antibody-evading virus vectors
|
MX2018004366A
(en)
|
2015-10-09 |
2018-08-01 |
Genzyme Corp |
Early post-transfection isolation of cells (epic) for biologics production.
|
US10123969B2
(en)
|
2015-10-15 |
2018-11-13 |
Wisconsin Alumni Research Foundation |
Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid
|
WO2017070476A2
(en)
|
2015-10-22 |
2017-04-27 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav3 capsid library
|
EP3364996B1
(en)
|
2015-10-22 |
2021-08-25 |
University of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
WO2017070525A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance in neurodegenerative disease
|
JP7190352B2
(en)
|
2015-10-23 |
2022-12-15 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
Methods of treating neurodegenerative diseases using gene therapy to delay disease onset and progression while providing cognitive protection
|
US20180230489A1
(en)
|
2015-10-28 |
2018-08-16 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
EP3371217A1
(en)
|
2015-11-08 |
2018-09-12 |
H. Hoffnabb-La Roche Ag |
Methods of screening for multispecific antibodies
|
WO2017083423A1
(en)
|
2015-11-10 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating aav infection
|
SG10202106287YA
(en)
|
2015-12-01 |
2021-07-29 |
Spark Therapeutics Inc |
Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
|
US20170151416A1
(en)
|
2015-12-01 |
2017-06-01 |
Invivo Therapeutics Corporation |
Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
EP3384034B1
(en)
|
2015-12-02 |
2020-07-08 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
WO2017093330A1
(en)
|
2015-12-03 |
2017-06-08 |
Genethon |
Compositions and methods for improving viral vector efficiency
|
US11499165B2
(en)
|
2015-12-11 |
2022-11-15 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
EP3387118B1
(en)
|
2015-12-11 |
2022-04-06 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
US11015174B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV8
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
EP3403675B1
(en)
|
2016-01-15 |
2021-04-21 |
Jichi Medical University |
Adeno-associated virus virion for use in treatment of epilepsy
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
DK3411484T3
(en)
|
2016-02-05 |
2023-11-20 |
Univ Emory |
INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS 9 INTO THE CEREBROSPINAL FLUID
|
EP3426787A1
(en)
|
2016-03-07 |
2019-01-16 |
University of Iowa Research Foundation |
Aav-mediated expression using a synthetic promoter and enhancer
|
EP3429605A4
(en)
|
2016-03-18 |
2019-09-18 |
The Children's Hospital of Philadelphia |
Therapeutic for treatment of diseases including the central nervous system
|
JP7366388B2
(en)
|
2016-03-28 |
2023-10-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Anti-Ryk antibody and its use
|
US11091776B2
(en)
|
2016-04-15 |
2021-08-17 |
The Trustees Of The University Of Pennsylvania |
AAV8 mutant capsids and compositions containing same
|
EP3235516B1
(en)
|
2016-04-22 |
2019-06-26 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin |
Regulatable adeno-associated virus (aav) vector
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
EP3452495B1
(en)
|
2016-05-03 |
2021-06-23 |
Children's Medical Research Institute |
Adeno-associated virus polynucleotides, polypeptides and virions
|
WO2017192750A1
(en)
|
2016-05-04 |
2017-11-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
IL297576B2
(en)
|
2016-05-18 |
2024-02-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
MX2018014154A
(en)
|
2016-05-18 |
2019-05-06 |
Voyager Therapeutics Inc |
Modulatory polynucleotides.
|
AU2018260998A1
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
JP2020518258A
(en)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
Amyotrophic lateral sclerosis (ALS) treatment composition and method
|
US20220090127A1
(en)
|
2017-06-02 |
2022-03-24 |
Institut National De La Sante Et De La Recherche Medicale (Inserm |
Viral vector combining gene therapy and genome editing approaches for gene therapy of genetic disorders
|
CA3071978A1
(en)
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
JP2021502060A
(en)
|
2017-10-16 |
2021-01-28 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
Treatment of amyotrophic lateral sclerosis (ALS)
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
CA3103963A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
WO2020010035A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Cannula system
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
WO2020223296A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|